2nd RSC Anglo-Nordic Medicinal Chemistry Symposium


Tuesday-Friday, 11th-14th June 2019

Hotel Comwell Borupgaard, Snekkersten, Denmark


Registration is open


Twitter hashtag - #ANMC19


Downloads and Links

Registration form - for payment by bank transfer

Online registration - for payment by card


First announcement

Poster abstract template - closing date is 30th April 2019

Bursary application form - closing date is 16th April


Venue website (showing location)

National travel information website

RSC website



This 2.5 day symposium follows on from the very successful inaugural meeting held in 2017 containing high quality international speakers from industry and academia on topics of Medicinal Chemistry and related enabling technologies. Organised by the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry, together with Nordic affiliates, the meeting promises to be an exciting and invigorating gathering packed with fantastic opportunities to disseminate knowledge and expand networks.


Programme Themes and Features

The scientific programme will feature themed lectures, focusing on medicinal chemistry and related technologies and disciplines across a range of drug targets and modalities. A distinguishing feature of this symposium is the collegiate style which encourages an atmosphere of information sharing and learning.

The event will include first rate lectures, poster session, trade exhibition, ample networking opportunities, welcome buffet on Tuesday, exceptional location, venue and accommodation.


Who should attend

Medicinal chemists at all career stages. Scientists with an interest in drug discovery or new technologies that can be applied to the drug discovery process.


Call for Posters

The call for posters is open, and papers are invited for poster presentation. The closing date is 30th April 2019, and some posters will be selected for flash oral presentation.


Download an abstract template here.


The call for oral abstracts closed on 31st October 2018.


Outline Programme

Tuesday 11th June
18:00 Registration, welcome reception and buffet supper
21:00 Close

Wednesday 12th June
08:30 Registration
09:30 Technical programme starts

12.40 Lunch

13.40 Technical programme resumes (flash posters)

14.30 Poster session

16.00 Technical programme resumes
17.30 Technical programme ends
19.00 Dinner

Thursday, 13th June
08.30 Registration

09.00 Technical programme starts

12.10 Lunch

13.10 Free time to enjoy the hotel and spa

15.00 Technical programme resumes
17.30 Technical programme ends
19.00 Conference dinner

Friday, 14th June
08.45 Registration

09.00 Technical programme starts
12.10 Technical programme ends
12.10 Lunch and depart


Confirmed Speakers

Discovery of H3B-8800, a novel, orally bioavailable, small molecule, splice modulator

Andrew Cook, H3 Biomedicine, USA


Resetting the antibacterial arms race: LepB as a novel gram negative target

James Crawford, Genentech, USA


Lowering lipophilicity by adding carbon - building bridges to improve physicochemical properties of drug molecules
Sébastien Degorce, AstraZeneca, UK


Provisionally:  Translating RNA sequence into lead small molecule medicines

Matthew Disney, Scripps Research, USA


Discovery of the TYK2 selective inhibitor PF-6826647 for the treatment of Crohn’s disease, and other autoimmune conditions
Brian Gerstenberger, Pfizer Inc, USA


Target validation with chemical probes: reproducing pharmacology and safety aspects of the phenotype of Rorc-deficient mice with RORC2 inverse agonists in rats

Samuel Hintermann, Novartis, Switzerland


Discovery and characterization of highly potent and selective allosteric USP7 inhibitors
Colin O'Dowd, Almac Discovery, UK

AZD5718, a clinical inhibitor of Five-Lipoxygenase-Activating-Protein (FLAP) for treatment of Coronary Artery Disease (CAD)
Daniel Pettersen, AstraZeneca, Sweden


Nucleoside reverse transcriptase translocation inhibitors to enable extended duration dosing
Izzat Raheem, Merck, USA


Rewriting the (tran)script: discovery of Risdiplam

Hasane Ratni, Roche, Switzerland


Discovery of the oral LTC4S inhibitor AZD9898 as a new treatment for asthma
Lena Ripa, AstraZeneca, Sweden

Optimising PROTACs towards the clinic: turning promises of low dose and long duration into reality

Ian Smith, GlaxoSmithKline, UK

Identification of a novel oxadiazole RORg antagonist – a balancing act
Morten Dahl Sørensen, LEO Pharma, Denmark


Discovery of GLPG2451, a novel potentiator for the treatment of cystic fibrosis
Steven Van Der Plas, Galapagos, Belgium


Structurally enabled discovery of innovative Calcitonin Gene-Related Peptide (CGRP) receptor antagonists
Steve Watson, Heptares, UK

Registration, Fees, and Bursaries

Registration form - for payment by bank transfer

Online registration - for payment by card


The previous meeting was very popular and oversubscribed such that capacity has been increased to 140 attendees for 2019. Discounted rates are offered to RSC members and limited student bursaries are available.

Registration fees include the Tuesday evening welcome buffet.

Early rates for payments received by 22nd March
£525 RSC member
£605 Non-member
£400 RSC student* member
£440 Student* non-member

Standard rates for payments received between 23rd March and 10th May
£575 RSC member
£655 Non-member
£450 RSC student* member
£490 Student* non-member

Late rates for payments received from 11th May onwards
£55   Late payment fee was added to the above standard rates

* Student is undergraduate or post-graduate, not post-doc, and does not apply to students in paid employment.
Member is paid-up member of the RSC.

Some student bursaries are available for this meeting (funded by the RSC-BMCS). The closing date for applications is 16th April.  Please download a
bursary application form here.



Exhibition stands are priced at £1,100, and this fee includes for one full delegate with access to the technical programme.


Each exhibitor stand will comprise a space measuring 1.5 metres wide with electricity and a table measuring 1.5 m wide x 0.75 m deep x 0.72 m high.


Delegate pack inserts may be booked at £275 (sponsor to supply), comprising no more than two pages of A4 fixed together.



The accommodation and dinners package is priced at £585, and  comprises:
- three nights’ bed and breakfast accommodation at the conference Hotel Comwell Borupgaard (from Tuesday to Thursday inclusive)
- three-course dinner with drinks on Wednesday
- conference dinner with drinks on Thursday
It is advisable to book this at the time of registration.


Venue and Travel

Address:  Hotel Comwell Borupgaard, Nørrevej 80, Snekkersten 3070, Denmark


Travel (with guide prices - please check for yourself): 

By train:  55 minutes from Copenhagen airport/railway station to Snekkersten.   Cost £10-£17

By taxi:  45 minutes from Copenhagen airport/railway station to Snekkersten.  Cost £95-£100

By bus and train:  1h 50m from Copenhagen airport/railway station to Snekkersten.  Cost £7-£20



A location map may be found here

A map with travel modes and charges from Copenhagen station may be found here.

National travel information website



We are grateful to our confirmed sponsors, AstraZeneca, LEO Pharma, Lundbeck, and Vipergen for their valued support. Additional sponsors are sought.



Organising Committee

Sharan Bagal (chair)AstraZeneca UK
Kevin N DackLEO Pharma
Adrian HallUCB
Morten JørgensenLundbeck
Malin LemurellAstraZeneca Sweden


Secretariat Contact

Maggi Churchouse Events, 3 East Barn, Market Weston Road, Thelnetham, Diss IP22 1JJ, UK


Telephone: +44 (0)1359 221004


Registration is open